Pharmabiz1d
Daiichi Sankyo begins patient dosing in QuANTUM-Wild phase 3 trial of Vanflyta in newly diagnosed FLT3-ITD negative AML
Daiichi Sankyo begins patient dosing in QuANTUM-Wild phase 3 trial of Vanflyta in newly diagnosed FLT3-ITD negative AML: Tokyo Thursday, December 12, 2024, 12:00 Hrs [IST] The fir ...
Daiichi Sankyo doses first subject in Phase III AML therapy trial
Daiichi Sankyo has announced the dosage of the first subject in the randomised Phase III QuANTUM-Wild trial of oral Vanflyta ...
Le Lézard2d
IonQ Highlights Continued Quantum Momentum at Q2B24 Silicon Valley
IonQ , a leader in the quantum computing and networking industry, will highlight the transformative power of quantum computing for the future of business at Q2B24 Silicon Valley. At Q2B24, IonQ will ...
QuANTUM-Wild Phase 3 Trial of VANFLYTA® Initiated in Patients with Newly Diagnosed FLT3-ITD Negative AML
The first patient has been dosed in the QuANTUM-Wild phase 3 trial evaluating Daiichi Sankyo’s (TSE: 4568) VANFLYTA® ...
CTV News23d
Runway to be closed for 'at least several days' after cargo jet incident at Vancouver airport
One of the runways at Vancouver International Airport will be closed for several days after a jet carrying Amazon packages overran it Tuesday morning. The Prime Air Boeing 767-300 operated by ...